Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Globe Life Inc. (NYSE:GL ) Q2 2025 Earnings Conference Call July 24, 2025 11:00 AM ET Company Participants Frank Martin Svoboda - Co-Chairman & Co-CEO James Matthew Darden - Co-Chairman & Co-CEO Stephen Mota - Senior Director of Investor Relations Thomas Peter Kalmbach - Executive VP & CFO Conference Call Participants Andrew Scott Kligerman - TD Cowen, Research Division Elyse Beth Greenspan - Wells Fargo Securities, LLC, Research Division Jack Matten - BMO Capital Markets Equity Research Jamminder Singh Bhullar - JPMorgan Chase & Co, Research Division John Bakewell Barnidge - Piper Sandler & Co., Research Division Mark Douglas Hughes - Truist Securities, Inc., Research Division Ryan Joel Krueger - Keefe, Bruyette, & Woods, Inc., Research Division Suneet Laxman L. Kamath - Jefferies LLC, Research Division Thomas George Gallagher - Evercore ISI Institutional Equities, Research Division Wesley Collin Carmichael - Autonomous Research US LP Wilma Carter Jackson Burdis - Raymond James & Associates, Inc., Research Division Operator Hello, and welcome to Globe Life Inc. Second Quarter Earnings Release Call.
GL's Q2 earnings increase 10% as strong Life and Health premiums offset declines in investment income and rising expenses.
Globe Life (GL) came out with quarterly earnings of $3.27 per share, beating the Zacks Consensus Estimate of $3.25 per share. This compares to earnings of $2.97 per share a year ago.
Investors need to pay close attention to GL stock based on the movements in the options market lately.
Get a deeper insight into the potential performance of Globe Life (GL) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Globe Life (GL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Globe Life is set to grow on well-performing American Income and Liberty National divisions, higher invested assets and a strong liquidity position.
I highlight four American SWAN stocks - Realty Income, Alphabet, Globe Life, and Thermo Fisher Scientific - offering stress-free, blue-chip investment opportunities. Each company boasts strong management, robust balance sheets, consistent earnings, and attractive valuations, trading 18-24% below my fair value estimates. These stocks offer a blended 1.8% yield, low payout ratios, and A or AA credit ratings, supporting reliable dividend growth and low long-term risk.
The Magnificent Seven are often in the spotlight, but not because of any major shifts in their businesses. Some could call it a proverbial flip of the narrative switch to shine the lights on the usual suspects to stir up some fresh buying activity.
Globe Life gains from premium growth, higher invested assets and a strong liquidity position. Escalating expenses and high leverage are major concerns.
Globe Life (GL) reported earnings 30 days ago. What's next for the stock?